Salta al contenuto principale
Ricerc@Sapienza
Toggle navigation
Home
Login
Home
Persone
annateresa.palamara@uniroma1.it
Anna Teresa Palamara
Professore Ordinario
Struttura:
DIPARTIMENTO DI SANITA' PUBBLICA E MALATTIE INFETTIVE
E-mail:
annateresa.palamara@uniroma1.it
Pagina istituzionale corsi di laurea
Curriculum Sapienza
Pubblicazioni
Titolo
Pubblicato in
Anno
Chronic intestinal pseudo-obstruction: associations with gut microbiota and genes expression of intestinal serotonergic pathway
BMC MICROBIOLOGY
2024
Effectiveness against severe COVID-19 of a seasonal booster dose of bivalent (original/Omicron BA.4-5) mRNA vaccines in persons aged ≥60 years: Estimates over calendar time and by time since administration during prevalent circulation of different Omicron subvariants, Italy, 2022–2023
VACCINE
2024
In vivo evolution to hypermucoviscosity and ceftazidime/avibactam resistance in a liver abscess caused by Klebsiella pneumoniae sequence type 512
MSPHERE
2024
Anisakis extracellular vesicles elicit immunomodulatory and potentially tumorigenic outcomes on human intestinal organoids
PARASITES & VECTORS
2024
Acinetobacter baumannii OmpA-like porins: functional characterization of bacterial physiology, antibiotic-resistance, and virulence
COMMUNICATIONS BIOLOGY
2024
HSV-1 infection induces phosphorylated tau propagation among neurons via extracellular vesicles
MBIO
2024
A Serum Multi-Parametric Analysis Identifies an Early Innate Immune Signature Associated to Increased Vaccine-Specific Antibody Production and Seroconversion in Simultaneous COVID-19 mRNA and Cell-Based Quadrivalent Influenza Vaccination
VACCINES
2024
Functional diversification of innate and inflammatory immune responses mediated by antibody fragment crystallizable activities against SARS-CoV-2
ISCIENCE
2024
SINGLE CELL MULTI-OMIC ANALYSIS OF THE INNATE IMMUNE COMPARTMENT REVEALS A SARS-CoV-2-SPECIFIC PHENOTYPE IN HUMAN MONOCYTES
Frontiers in Microbiology
2024
Reduction of the risk of severe COVID-19 due to Omicron compared to Delta variant in Italy (November 2021 - February 2022)
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
2023
Influenza virus replication is affected by glutaredoxin1-mediated protein deglutathionylation
THE FASEB JOURNAL
2023
Targeting SARS-CoV-2 by synthetic dual-acting thiol compounds that inhibit Spike/ACE2 interaction and viral protein production
THE FASEB JOURNAL
2023
Insightful improvement in the design of potent uropathogenic E. coli fimh antagonists
PHARMACEUTICS
2023
NRF2 Antioxidant Response and Interferon-Stimulated Genes Are Differentially Expressed in Respiratory-Syncytial-Virus- and Rhinovirus-Infected Hospitalized Children
PATHOGENS
2023
Genetic diversity and its impact on disease severity in respiratory syncytial virus subtype-A and -B bronchiolitis before and after pandemic restrictions in Rome
JOURNAL OF INFECTION
2023
Relative effectiveness of monovalent and bivalent mRNA boosters in preventing severe COVID-19 due to omicron BA.5 infection up to 4 months post-administration in people aged 60 years or older in Italy: a retrospective matched cohort study
THE LANCET INFECTIOUS DISEASES
2023
Relative effectiveness of bivalent Original/Omicron BA.4-5 mRNA vaccine in preventing severe COVID-19 in persons 60 years and above during SARS-CoV-2 Omicron XBB.1.5 and other XBB sublineages circulation, Italy, April to June 2023
EUROSURVEILLANCE
2023
Atopic dermatitis-derived Staphylococcus aureus strains: what makes them special in the interplay with the host
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY
2023
Relative effectiveness of a 2nd booster dose of COVID-19 mRNA vaccine up to four months post administration in individuals aged 80 years or more in Italy. A retrospective matched cohort study
VACCINE
2023
Estimated effectiveness of a primary cycle of protein recombinant vaccine nvx-cov2373 against covid-19
JAMA NETWORK OPEN
2023
1
2
3
4
5
6
7
seguente ›
ultima »
© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma